Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.70
Delayed Data
As of 12:52pm ET
 -0.02 / -0.54%
Today’s Change
1.62
Today|||52-Week Range
5.79
+38.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues41.5K149.8K52.0K40.4K
 
 
 
 
 
Cost of Goods Sold50.7K41.4K45.2K35.8K
 
 
 
 
 
Depreciation And Amortization711.00710.00710.001.3K
 
 
 
 
 
 
Operating ExpensesGross Income-9.9K107.7K6.1K3.3K
 
 
 
 
 
General Expenses3.3M3.9M3.1M2.8M
 
 
 
 
 
Research And Development1.7M1.5M2.0M1.6M
 
 
 
 
 
Total Operating Expenses3.3M3.9M3.1M2.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.3M-3.8M-3.0M-2.8M
 
 
 
 
 
Interest Expense On Debt58.3K54.1K78.3K49.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.3M-3.8M-3.1M-2.8M
 
 
 
 
 
Net Income-3.3M-3.8M-3.1M-2.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.0M45.4M46.9M49.1M
 
 
 
 
 
Shares To Calculate EPS Diluted46.0M45.4M46.9M49.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.08-$0.07-$0.05
 
 
 
 
 
EPS Diluted-$0.08-$0.08-$0.07-$0.06